Margarida Alves

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

Oliver Distler, Kristin B. Highland, Martina Gahlemann et al. · New England Journal of Medicine · 2019 · 1.5K citations · Full text

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database

Anna‐Maria Hoffmann‐Vold, Yannick Allanore, Margarida Alves et al. · Annals of the Rheumatic Diseases · 2020 · 335 citations · Full text

Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial

James R. Seibold, Toby M. Maher, Kristin B. Highland et al. · Annals of the Rheumatic Diseases · 2020 · 69 citations · Full text

Effect of Nintedanib on Lung Function in Patients With Systemic Sclerosis−Associated Interstitial Lung Disease: Further Analyses of a Randomized, Double‐Blind, Placebo‐Controlled Trial

Toby M. Maher, Maureen D. Mayes, Michael Kreuter et al. · Arthritis & Rheumatology · 2020 · 41 citations · Full text

Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ON

Yannick Allanore, Madelon C Vonk, Oliver Distler et al. · Annals of the Rheumatic Diseases · 2022 · 40 citations · Full text